Abstract:Background: Gastrin/cholecystokinin subtype 2 receptor (CCK2R) is overexpressed in several types of tumors. Gastrin-17 (G17) peptide has a high affinity with CCK2R. These characters suggest that G17 may be useful for target cancer therapy.Purpose: Construct a new immunotoxin (IT) targeting of CCK2R overexpressed gastric cancer.Methods: Two ITs were generated using forward and reverse G17 peptides fused with PE38. To get a high yield, codon optimized gene and optimized fermentation parameters were used in large-scale protein expression. An immunoaffinity technique was introduced into pseudomonas exotoxin (PE)-derived IT purification procedure. G17 competition, GST pull-down and indirect immunoflourescence assays were carried out to confirm the interaction between rG17 and CCK2R. Then, several cytotoxic assays were carried out on 18 cell lines, and an in vivo antitumor activity experiment was tested in nude mice.Results: The rG17PE38 showed specific cytotoxicity on three gastric cancer cells, while G17PE38 did not. After optimization, the expression level reached about 40% in medium deprived of NaCl. Next, 15-27.5mg of pure rG17PE38 per 1 L of cultures was obtained. Results of G17 competition, GST pull-down and indirect immunoflourescence assays demonstrated that rG17 have a specific interact with CCK2R. Purified rG17PE38 showed high cytotoxicity on gastric cancer cell lines with the IC50 value of 0.6-4 ng.mL(-1). Treatment of nude mice inoculated with BGC-823 tumor xenografts with rG17PE38 efficiently inhibited tumor size.Conclusions and discussion: The present study demonstrates that reversed G17 could be used as target moiety of PE-derived IT and the rG17PE38 could be developed as a new immunotherapy agent. Codon optimized gene could increase the rG17PE38 expression level in E. coli and furthermore NaCl inhibits the rG17PE38 expression in large scale. Meanwhile, our present study inducts an immunoaffinity method in the IT purification procedure, which could purify the PE-derived ITs in native form.

An Efficient Scheme for Purification of a Novel Recombinant Immunotoxin, Rcck8pe38, for Anti-Tumour Experiments.

A novel immunotoxin - rCCK8PE38 targeting of CCK-R overexpressed colon cancers.

Characterization of Recombinant Toxin rCCK96-104PE38 Targeting Colon Cancer

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

[Construction, Expression and Purification of a Mammalian Secretory Recombinant Fusion Protein Rpc].

Establishment of a Three-Step Purification Scheme for a Recombinant Protein Rg17pe38 and Its Characteristics Identification.

[High Level Expression, Purification and Cytotoxicity of IL-10(18-57)-PE40].

Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin A.

Study of Scale Purification and Anti-tumor Efficacy of R9-FOXM 1(1-234aa) Recombinant Protein

Purification and Characterization of Rgd Tumor-Homing Peptide Conjugated Human Tumor Necrosis Factor Alpha Over-Expressed in Escherichia Coli

Expression and Purification of Recombinant Human Tumor Necrosis Factor α in Escherichia Coli

Expression and functional detection of recombinant immunotoxins anti-B7-H4-scFv/PE38KDEL

Rg17pe38, a Novel Immunotoxin Target to Gastric Cancer with Overexpressed CCK-2R.

The Construction of Anti-EGFR Single Chain Variable Fragment Fused with Gelonin Toxin Prokaryotic Expressing Plasmid and the Study of Its Anti-tumor Effects

[Construction and Functional Analysis of a Novel Eukaryotic Expression Plasmid of Recombinant Immunotoxin DT390-Rantes].

Refolding and Purification of Recombinant Toxin DT389-IL13

Purification of clinical-grade disulfide stabilized antibody fragment variable— Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli

[Prokaryotic Expression and Purification of RPS13 and Preparation of Polyclonal Antibody Against RPS13].

Expression, Purification, and Characterization of Recombinant Protein GX1-rmhTNFα

Design, Expression, Purification and Characterization of the Recombinant Immunotoxin 4D5 Scfv-Trail

Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL